Process Improvements. Following Facility Approval, ACSD may continue operating [*] with the [*]. Development undertaken for the purpose of [*] will be [*]. ACSD will [*]. All modifications in raw materials, conditions or processing related to the manufacture of Product will be implemented [*]. The [*] following a successful and complete cGMP change control process outlined in the [*].
Appears in 2 contracts
Sources: Manufacturing Agreement (Cubist Pharmaceuticals Inc), Manufacturing and Supply Agreement (Cubist Pharmaceuticals Inc)
Process Improvements. Following Facility Approval, ACSD may continue operating [*[ * ] with the [*[ * ]. Development undertaken for the purpose of [*[ * ] will be [*[ * ]. ACSD will [*[ * ]. All modifications in raw materials, conditions or processing related to the manufacture of Product will be implemented [*[ * ]. The [*[ * ] following a successful and complete cGMP change control process outlined in the [*[ * ].
Appears in 1 contract
Sources: Manufacturing Agreement (Cubist Pharmaceuticals Inc)